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B I O P H Y S I C S
HspB1 phosphorylation regulates its intramolecular 
dynamics and mechanosensitive molecular chaperone 
interaction with filamin C
Miranda P. Collier1*, T. Reid Alderson1, Carin P. de Villiers2, Daisy Nicholls1, Heidi Y. Gastall1, 
Timothy M. Allison1,3, Matteo T. Degiacomi1,4, He Jiang2, Georg Mlynek5, Dieter O. Fürst6, 
Peter F. M. van der Ven6, Kristina Djinovic-Carugo5,7, Andrew J. Baldwin1, Hugh Watkins2, 
Katja Gehmlich2,8†, Justin L. P. Benesch1†
Mechanical force–induced conformational changes in proteins underpin a variety of physiological functions, typified 
in muscle contractile machinery. Mutations in the actin-binding protein filamin C (FLNC) are linked to musculo-
skeletal pathologies characterized by altered biomechanical properties and sometimes aggregates. HspB1, an 
abundant molecular chaperone, is prevalent in striated muscle where it is phosphorylated in response to cues 
including mechanical stress. We report the interaction and up-regulation of both proteins in three mouse models 
of biomechanical stress, with HspB1 being phosphorylated and FLNC being localized to load-bearing sites. We 
show how phosphorylation leads to increased exposure of the residues surrounding the HspB1 phosphosite, facili-
tating their binding to a compact multidomain region of FLNC proposed to have mechanosensing functions. 
Steered unfolding of FLNC reveals that its extension trajectory is modulated by the phosphorylated region of 
HspB1. This may represent a posttranslationally regulated chaperone-client protection mechanism targeting 
over-extension during mechanical stress.
INTRODUCTION
Mechanosensitive proteins withstand cycles of force-induced structural 
changes and hence have a pliable “native” state. This is critical for 
their function, whether to provide elasticity to cells and tissues, open 
and close a channel in the membrane, or reveal cryptic or force-enhanced 
binding sites in mechanotransductive signaling pathways (1). Exces-
sive force, however, can lead to loss of function due to unfolding 
and subsequent formation of deleterious aggregates that overburden 
the capacity of the protein quality control network (2). These patho-
logical deposits of intracellular proteins underlie a variety of muscle 
myopathies (3, 4). To counter the effects of misfolding in general, 
cells invest in molecular chaperones. The frequent association of one 
class of chaperone in particular, the adenosine triphosphate (ATP)–
independent small heat shock proteins (sHsps, HspBs) (5), with the 
cytoskeletal support network (6, 7) and muscle contractile machinery 
(8) suggests a role for mechanosensitivity in sHsp-client binding.
One potential interaction is between HspB1 (also known as 
Hsp27 in humans) and filamin C (FLNC; also known as -FLN; 
ABP-L; FLN2). Filamins, of which there are three paralogs in 
adult humans, are large modular proteins that play key roles in 
signaling pathways, cytoskeletal organization, cellular motility, 
and differentiation (9). They cross-link cytoskeletal actin into 
branched three- dimensional networks and are components of 
adhesion assemblies. FLNC, found almost exclusively in striated 
muscle, associates with thin filaments of sarcomeric actin at the 
myofibrillar Z-discs and intercalated discs (Fig. 1A) (10). Alter-
ations in the human FLNC gene can lead to severely impaired 
myoarchitecture and deposits of large protein aggregates and were 
initially linked to skeletal myopathies (designated “filaminopathies”), 
with some carriers also displaying cardiac abnormalities (11). 
Recently, the range of known disease- linked FLNC alleles has ex-
panded in association with various cardiac pathologies, often with-
out skeletal manifestation (12, 13). HspB1 is also prevalent in 
aggregates from patients with filaminopathy (14) and at sarco-
meric lesions with FLNC (15), suggesting a possible association 
during stress.
Human filamins are ≈280-kDa homodimers, each monomer consist-
ing of an N-terminal actin-binding domain followed by 24 immuno-
globulin (Ig)–like domains (d1 to d24), the last of which mediates 
dimerization (Fig. 1A). The distal region (d16 to d24) encompasses 
the binding sites for most filamin partners (9), which appear to include 
HspB1, because this interaction was first detected in yeast two-hybrid 
assays using the segment d19–d21 of FLNC (16). The distal region of 
filamin A (FLNA) can sense mechanical cues by partially extending 
under force to reveal cryptic binding sites (17). FLNC contains a large 
insertion within d20, and less is known about its structure and the 
molecular basis of its roles. Evidence that FLNC can sense local force 
includes functionality that necessitates a degree of plasticity in response 
to tension (18), 73% sequence identity and overlapping roles and 
binding partners with FLNA (19), the ability to protect myofibrillar 
structural integrity (20), and differential in-cell labeling of shielded 
cysteines with applied force (21).
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Each HspB1 monomer is composed of a conserved core -crystallin 
domain (ACD) flanked by a short flexible C-terminal region, which 
makes intra-oligomer contacts, and a longer N-terminal domain 
(NTD) (5). The NTD also confers oligomeric stabilization, with 
phosphorylation at Ser15 and Ser78 or Ser82 causing a shift from a large 
polydisperse ensemble to smaller oligomeric species, including 
dimers (22, 23). HspB1 is phosphorylated in cells and tissues in re-
sponse to stretch, inducing translocation to the Z-discs (24, 25) and 
to regions of increased traction force within the cytoskeleton (26), 
suggesting that phosphorylation may trigger or modulate its inter-
actions with mechanosensitive clients such as FLNC at these sites.
To investigate the impact of phosphorylation on HspB1 intra- 
oligomer contacts and its interaction with FLNC, we used experimental 
approaches spanning the tissue to atomic levels. We validated the 
proposed interaction between FLNC and HspB1 and noted up-regulation 
and partial colocalization of both proteins, including the phospho-
rylated form of HspB1, in biomechanically challenged mouse hearts. 
We found that a segment of the NTD just downstream of the ACD 
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Fig. 1. FLNC and HspB1 are up-regulated in MLP KO mouse heart and interact via domains 18 to 21 in a phosphorylation-dependent manner. (A) Schematic of 
FLNC composition and localization in striated muscle at the Z-disc and intercalated disc. Gray lines, multiple Z-disc proteins, including -actinin, desmin, etc. Adaptors: talin, 
vinculin, catenins, etc. PM, plasma membrane. ABD, actin-binding domain of FLNC. Not pictured: possible localization at costameres. (B) Frozen sections of ventricular 
tissue from WT and MLP KO mice. Sections were stained for FLNC and counterstained to visualize sarcomeres (myomesin) and intercalated discs (N-cadherin). Scale bar, 10 m. 
FLNC is primarily localized at intercalated discs and sarcomeric Z-discs (blue and red striped arrows, respectively) and is more abundant in the DCM tissue. (C) Immuno-
precipitation (IP) from MLP KO ventricular tissue lysate using an FLNC-specific antibody or isotype control and lysate control. Molecular masses from positions of markers. 
Asterisk indicates signal from antibody chains. HspB1 coprecipitates with FLNC, evidencing an interaction between the endogenous proteins. (D) Western blots from WT 
and MLP KO mouse heart homogenates for FLNC, HspB1, PHspB1, and GAPDH (glyceraldehyde phosphate dehydrogenase) as a loading control. Both FLNC and HspB1 
were up-regulated in MLP KO hearts, and HspB1 was phosphorylated at Ser86 (equivalent to human Ser82). (E) Recombinant EEF-tagged FLNCd18–21 mixed with T7-tagged 
HspB1 and immunoprecipitated. T7 antibody (but not an isotype control) pulled down both HspB1 and FLNCd18–21, indicating binding between the recombinant proteins. 
Neither protein is pulled down when T7-HspB1 is omitted from the sample. (F) Pelleted fraction of mixtures of recombinant FLNCd18–21 and WT or 3PHspB1 over the course 
of 90-min incubation at 25°C. Measurements by densitometry of SDS–polyacrylamide gel electrophoresis (PAGE).
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in HspB1 adopts a range of conformations and determined how 
they are modulated by phosphorylation to trigger oligomer dissoci-
ation. A peptide segment from this flexible region binds multiple 
FLNC Ig domains. Performing coulombically steered unfolding in 
the gas phase as a proxy for the mechanical forces FLNC experiences 
in vivo allowed us to probe features of the interaction that are invisible 
at rest. This revealed that phosphorylated HspB1 inhibits a partially 
extended form of FLNC from further unfolding. Our results support 
a force-resistant binding mode between a molecular chaperone and 
a mechanosensitive target that is modulated by phosphorylation 
and may be important for cardiac function upon myoarchitectural 
perturbation.
RESULTS
FLNC and HspB1 are up-regulated and interact 
in biomechanically stressed mouse hearts
We sought to test the association between HspB1 and FLNC in car-
diac tissue. To examine the effect of impaired cardiac biomechanics 
on FLNC expression and localization, we first used muscle LIM 
protein (MLP) knockout (KO) mice. MLP, like FLNC, is specific to 
striated muscle, and the phenotype of mice lacking MLP reproduces 
the morphology of dilated cardiomyopathy (DCM) and heart failure 
in humans (27). Frozen sections of ventricular tissue from wild-type 
(WT) and MLP KO mice were stained for FLNC and counterstained 
to visualize sarcomeric structure (myomesin) and intercalated discs 
(N-cadherin) (Fig. 1B). FLNC was located at intercalated discs and 
Z-discs at greater abundance in MLP KO hearts based on fluores-
cence intensity. This is consistent with previously reported FLNC 
localization (10) and with mechanosensitivity, given the role of in-
tercalated discs and Z-discs as force-bearing sites. A proportion of 
HspB1 was coimmunoprecipitated together with FLNC from lysates 
of MLP KO ventricular tissue, indicating an endogenous interaction 
(Fig. 1C). Western blotting from WT and MLP KO mouse heart 
lysates confirmed that FLNC was up-regulated in the diseased tissue 
relative to WT (Fig. 1D). HspB1 was also up-regulated, including its 
phosphorylated form (at S86, analogous to human S82, the most 
prevalently modified site; mouse HspB1 does not contain a phospho-
site equivalent to human S78; Fig. 1D).
We then asked whether FLNC and HspB1 are also up-regulated 
in WT hearts under biomechanical stress conditions. We subjected 
WT mice to transverse aortic constriction (TAC), an established pro-
cedure that results in pressure overload–induced cardiac hypertro-
phy and heart failure. TAC mouse hearts displayed higher levels of 
FLNC and HspB1 than sham WT hearts, as measured by Western 
blot (fig. S1A). Chronic treatment of WT mice with isoprenaline/
epinephrine (IsoPE), increasing blood pressure and heart rate 
through adrenergic stimulation (28), also resulted in up-regulation of 
both proteins (fig. S1B). Immunofluorescence of ventricular tissue 
from TAC- and IsoPE-treated mouse hearts showed FLNC at inter-
calated discs and Z-discs as in the MLP KO model (fig. S1C). We also 
observed varying degrees of colocalization of HspB1 with FLNC in 
all three groups (MLP KO, TAC, and IsoPE), with comparatively weak 
HspB1 signal in controls (fig. S1D).
Next, to validate the interaction in vitro, we expressed EEF-
tagged human FLNC domains 18 to 21, encompassing the apparent 
HspB1 binding site (16), and full-length human HspB1 attached to 
a T7 tag. Pulling down the HspB1 protein with the T7 antibody co-
immunoprecipitated FLNCd18–21 (Fig. 1E), confirming a direct inter-
action between these proteins. To investigate the effect of HspB1 
phosphorylation on the interaction, we expressed WT human 
HspB1 and 3PHspB1, a triple mutant containing phosphomimetic 
Ser to Asp substitutions at residues 15, 78, and 82. Upon incubation 
with FLNCd18–21 in vitro, we noticed that mixtures accumulated 
insoluble protein aggregates, while isolated proteins remained solu-
ble. In a 2:1 mixture of the chaperone to the FLNC fragment, both 
proteins migrated to the pelleted fraction over time, an effect that 
was substantially increased by phosphomimicry (Fig. 1F and fig. S2). 
The results support an interaction between HspB1 and FLNCd18–21 
to form large complexes that can be modulated by phosphorylation 
of HspB1.
Phosphomimicry reduces oligomer size and coincides 
with disorder in the N-terminal region of HspB1
Full-length HspB1 assembles into large, dynamic, and polydisperse 
oligomers that compromise its investigation at high resolution (5). 
To interrogate the regulatory role of phosphorylation, we therefore 
built on our previous construct of the structured ACD (HspB184–171), 
which does not assemble beyond a dimer but retains chaperone 
activity (29). We incorporated a small part of the NTD just upstream 
of the 2 strand, which we term the “principal phosphorylation 
region” (PPR), as it includes phosphosites Ser78 and Ser82 (HspB177–171). 
We also mutated these sites to mimic phosphorylation events 
(2PHspB177–171). Two-dimensional nuclear magnetic resonance 
(NMR) spectra of each of the three constructs featured well-dispersed 
resonances (Fig. 2A and fig. S3A), evidencing folded dimer structures. 
The HspB184–171 and HspB177–171 spectra overlay closely, with addi-
tional peaks in the region diagnostic of disorder (7.8 to 8.6 ppm in 
the 1H dimension) arising in the longer construct from the additional 
N-terminal residues (Fig. 2A). To examine the impact of phospho-
rylation on the PPR, we compared the NMR spectra of HspB177–171 
and 2PHspB177–171. We noted clear differences, particularly intensi-
fied signal in the disordered region for the phosphomimic, consis-
tent with an increase in flexibility (Fig. 2A and fig. S3A). Chemical 
shift–based order parameters and secondary structure propensities 
indicated a high degree of backbone flexibility and a low amount of 
secondary structure for the 2 strand and the PPR (Fig. 2B).
To visualize the structural fluctuations of 2, we performed a 
1-s molecular dynamics (MD) simulation of the HspB1 ACD 
starting from a structure [Protein Data Bank (PDB): 4MJH] in 
which the 2-strand is intramolecularly hydrogen-bonded to 3. 
We found that over the course of the simulation, 2 fluctuated con-
siderably, readily losing its secondary structure and detaching from 
the rest of the ACD (Fig. 2C). Calculation of the order parameters 
from the simulation reveals good correspondence with that from our 
NMR data (Fig. 2B) and is consistent with the disorder observed by 
others (30).
We next looked at chemical shift perturbations (CSPs) in the 
HspB1 ACD upon phosphomimicry. These were widely dispersed 
but small in magnitude (fig. S3B), supporting similarity of the ACD 
structures. To probe for effects on internal dynamics, we recorded 
15N spin relaxation measurements that monitor both picosecond- 
nanosecond and microsecond-millisecond motions. Whereas the 
fast dynamics were unaffected (fig. S3C), residues 95 to 110 (including 
the loop between 3 and 4) in the phosphomimic displayed evidence 
of conformational exchange on the slower timescale (Fig. 2B and 
fig. S3, D and E). We reasoned that this could indicate transient 
sampling of a lowly populated state involving contact between the 
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PPR and the ACD. The major state would then contain an unbound 
PPR, consistent with the small CSPs between HspB184–171 and 
HspB177–171 for residues 102 to 110, lack of any conformational ex-
change slow enough to give rise to multiple peaks, and flexibility of 
the N-terminal residues in solution (Fig. 2B).
The absence of notable broadening in the NMR spectra as a 
function of increasing HspB177–171 concentration suggested that the 
contacts made by the PPR regulate intradimer rather than interdimer 
binding. To test this hypothesis, we recorded mass spectra under 
conditions preserving noncovalent interactions. Applied to full-
length HspB1, this method has revealed a shift toward small species 
upon phosphomimicry, with predominant monomer and accompa-
nying dimer at low micromolar concentration (23). The new data 
showed that in the same concentration range, HspB177–171 populates a 
monomer-dimer equilibrium that is similarly shifted toward dissocia-
tion upon incorporation of one and two phosphomimics (Fig. 2, D and E). 
The absence of higher-order oligomers indicates that appreciable 
intermolecular binding of the PPR is unlikely in the context of the 
truncated construct, and the agreement between the full-length and 
truncation results supports the use of our construct in probing the 
link between phosphorylation-induced dynamics and quaternary 
organization. The combined NMR and mass spectrometry (MS) 
data are therefore consistent with phosphorylation modulating an 
order-to-disorder transition by 2 and the PPR that leads to oligomer 
dissociation via rearrangement of intradimer contacts.
The PPR of HspB1 interacts with a pocket in the ACD
We next carried out crystallographic trials, using a strategy of mix-
ing peptide mimics of the PPR, varying in length and degree of 
phosphorylation, with a well-ordered ACD construct (HspB184–170). 
This led to a structure of HspB184–170 bound to ALSRQLPSSGVSEI 
(residues 76 to 88 phosphorylated at Ser82), solved by molecular re-
placement in space group P1211, that contains four dimers in the 
asymmetric unit (table S1 and fig. S4A). The monomers within each 
dimer differ at their N-terminal ends: The 2 strand of one is intra-
molecularly hydrogen-bonded to its own 3 strand, whereas in the 
other these residues are extended and stabilized by contacts with a 
4-8 groove of a neighboring dimer (Fig. 3, A and B). This groove 
also acts as a binding pocket for an intrasubunit interface within the 
C-terminal region (fig. S4B) (29).
Upon refinement of the ACD, the 2Fo-Fc and difference density 
maps displayed a clear unmodeled feature occupying a pocket between 
the 3-4 and 8-9 loops, which lies on the side of the subunit 
close to the dimer interface. This feature was only present adjacent 
to subunits with intramolecularly bound 2 strands (fig. S4C). We 
were able to build peptides into this density but only accommodating 
subsets of the 11 possible residues, with their side-chain densities 
remaining poor in contrast to the ACD (see Materials and Methods). 
An ensemble of the four peptide-bound ACDs provides the best 
overview of the interaction available from these data (Fig. 3C). The 
binding site aligns with the dynamical changes we observed by 
NMR (Fig. 2, B and C). Our results reveal how the 2 strand and 
PPR assume heterogeneous conformations. Although predominately 
disordered in solution (Fig. 2, B and C), this region is also capable of 
making intramonomer associations with the 3 strand and stretch-
ing to the pocket between 3-4 and 8-9 loops (Fig. 3, B and C), 
as well as intersubunit interactions by occupying a 4-8 groove in 
a neighboring dimer (Fig. 3B). While it is not clear what the relative 
populations of these states are in the context of the full-length 
HspB1, they are consistent with multiple NTD conformations con-
tributing to maintaining sHsp assembly (5). Our combined data 
reveal that this heterogeneity is modulated by phosphorylation, 
resulting in changes in the stabilities of the interfaces that are likely 
responsible for shifting the equilibrium away from large oligomers 
toward smaller species.
HspB1 residues 80 to 88 bind multiple domains within FLNC
To isolate a stable HspB1-FLNCd18–21 complex and localize the 
binding within HspB1, we performed native ion mobility MS (IM-MS) 
experiments. FLNCd18–21 displayed an envelope of peaks centered on 
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low charge states, and a collision cross-section (CCS) of 37.2 ± 0.8 nm2 
(fig. S5A). This is consistent with a compact rather than linear archi-
tecture (fig. S5B), suggesting an inherently extensible conformation 
for this FLNC segment, wherein noncovalent interdomain interactions 
would be susceptible to rupture under force. Next, we mixed FLNCd18–21 
with either HspB184–171 or peptides mimicking the PPR, because 
this region is phosphorylated in the MLP KO mice (Fig. 1C) and gener-
ally upon biomechanical stress (26) and becomes exposed thereafter. 
This strategy of using segments of HspB1 meant that we could avoid 
the problems of insolubilization of the full-length protein upon inter-
action with FLNC d18–21, as well as generally mitigate the confounding 
effects associated with the chaperone’s intrinsic polydispersity. We 
were able to detect complexes between FLNCd18–21 and up to two 
copies of a peptide-containing part of the PPR, HspB180–88 (or its 
phosphorylated counterpart PHspB180–88) (Fig. 4A and fig. S5D). 
Complexes were not observed in mixtures of FLNCd18–21 with 
HspB184–171 (fig. S5C), suggesting that HspB1 residues 80 to 83 are 
critical, or with negative control peptides (fig. S5D), revealing a 
specific interaction with this segment of HspB1.
To measure the association of PHspB180–88 and HspB180–88 to 
FLNCd18–21, we recorded mass spectra at increasing peptide concen-
trations, now observing up to three copies bound (Fig. 4B and fig. S5F). 
By quantifying the relative abundances of FLNCd18–21 and the peptide- 
bound species, we could determine binding affinities (Fig. 4B, lower 
panel, and fig. S4G). We obtained similar dissociation constants 
(KDs) of 130 ± 17 M (HspB180–88) and 110 ± 10 M (PHspB180–88), 
indicating weak binding that is not affected substantially by phos-
phorylation. These findings contrast with the notable effect of 
HspB1 phosphomimicry on the interaction of full-length chaperone 
with the FLNC fragment (Fig. 1E). However, they can be rational-
ized by phosphorylation increasing the effective concentration of 
the binding region by modulating its conformational state (Fig. 2B 
and fig. S3) and leading to dimer (Fig. 2D) and oligomer disassem-
bly (22, 23). To localize binding of HspB180–88 to domains with Ig 
folds or to the d20 insertion (which is possibly disordered), we prepared 
a modified FLNC construct lacking the 82 insertion residues 
(FLNCd18–21,I). This construct also binds multiple HspB1 peptides 
(fig. S5E), indicating that HspB1 recognizes folded Ig domains of FLNC.
Phosphorylation modifies the extension 
of the FLNC-HspB1 complex
Having found marginal difference in binding affinities between the 
phosphorylated and unphosphorylated HspB1 peptides with 
FLNCd18–21 at equilibrium, we next sought to probe the strength of 
this interaction under the application of force. The motivation for 
this stemmed from the observation that the filamin distal region 
(Fig. 1A) undergoes extension in vivo (21), with FLNA domains 
even predicted to be able to unfold fully before breakage of the dimer 
interface, at physiologically relevant forces and loading rates (18, 31). 
Given the weakness of the FLNC-HspB180–88 complexes (>100 M, 
see above), and consequently their predicted low abundance at the 
concentrations compatible with force spectroscopy, we turned instead 
to an IM-MS alternative as a proxy for mechanical stress. Specifically, 
we performed experiments in which protein ions at a designated 
mass/charge (m/z) ratio are isolated in the mass spectrometer and 
activated selectively by collisions with inert gas, leading to conforma-
tional perturbations and chain extension steered by the coulombic 
repulsion between like charges (32).
Upon extending the HspB180–88:FLNCd18–21 complex by ramp-
ing the activation potential, we observed a gradual reduction in the 
abundance of peptide-bound FLNCd18–21, indicating dissociation of 
the peptide (Fig. 4C). Notably, phosphorylation of HspB180–88 
greatly increased the energy required to remove the peptide from 
FLNC: At 140 V, all unphosphorylated HspB180–88 had dissociated, 
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while PHspB180–88-bound FLNC persisted until 180 V (Fig. 4C, right). 
To quantify this differential dissociation behavior while avoiding 
potential cross-talk between charge states, we selected the 13+ ion 
of FLNCd18–21 bound to a single peptide in the mass spectrometer 
and performed analogous activation ramps (fig. S4H). This allowed 
us to extract the fraction of FLNCd18–21 associated with each peptide 
as a function of activation (Fig. 4C, lower). The breakdown curve 
for the FLNCd18–21:HspB180–88 complex revealed two inflection 
points, at ≈55 and ≈110 V. This suggests that HspB180–88 associates 
with FLNCd18–21 in (at least) two locations, consistent with the ob-
servation of multiple peptides binding in our titration experiments 
(Fig. 4B). PHspB180–88 dissociated less readily from FLNCd18–21, and 
the breakdown curve features only one inflection point at ≈130 V.This 
suggests that phosphorylation increases both the selectivity and 
strength of interaction of HspB1 with FLNC during coulombically 
steered extension.
To explore the phosphorylation-dependent differences between 
the FLNC-HspB1 peptide complex observed during extension 
(Fig. 4C) but not at rest (Fig. 4B), we used IM to examine the unfolding 
trajectory of FLNCd18–21. Over the range of activation potentials that 
dissociate HspB1 peptides from FLNCd18–21 (Fig. 4C), FLNCd18–21 
extends from the initial folded state (A) through an intermediate 
(B) to reach a final state (C) (Fig. 4D, upper). To validate this path-
way in the context of the biomechanics of FLNC, we asked whether 
we could correlate the transitions measured by IM to biologically 
functional events. Using shorter, two-domain FLNC constructs to 
increase the resolution of discrete unfolding transitions, we removed 
the first -strand from domain 20, which shields a binding site for 
signaling partners at cell adhesions that becomes exposed upon 
mechanical force (fig. S6A) (19, 33). This deletion resulted in abol-
ishment of the intermediate, meaning that a key step in the biological 
unfolding pathway is clearly reported by our gas-phase approach 
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(fig. S6B). For further validation, in the longer construct we used 
to assess binding to the HspB1 peptide (FLNCd18–21), we introduced 
a more conservative perturbation. Rather than delete the entire 
-strand, we engineered into it two substitutions (E2136R and 
I2138E). Again, the coulombically steered unfolding pathway was sig-
nificantly affected: while the stability of A, based on the potential 
required to transition to B, was unaffected, B was destabilized with 
respect to unfolding further to C (fig. S6C). These data therefore 
lead us to conclude not only that the gas-phase unfolding ap-
proach is biomechanically relevant but also that the FLNCd18–21 
transition B-C involves disruption of contacts made by the mechan-
ically functional d20 -strand.
The same three states were seen for FLNCd18–21 with either pep-
tide bound (Fig. 4D). In all cases, unfolding commenced at a lower 
potential than necessary for peptide dissociation. Therefore, HspB1 
does not exclusively bind the regions within FLNCd18–21 that extend 
first, because unfolding of a ligand-bound domain will coincide 
with ejection of the ligand (34). The stability of A was not altered by 
either peptide. State B, however, required more activation to transition 
to C when bound to PHspB180–88 (≈75 V) versus HspB180–88 (≈60 V) 
(Fig. 4D). This difference was consistent across charge states and 
instrument conditions (fig. S7). The data point to the formation of 
interactions when the phosphopeptide-bound FLNC structure is 
activated, leading to its increased resistance to extension, and disso-
ciation at higher potentials than the unmodified peptide (Fig. 4C). 
Given that the transition from B to C includes rupture of the -strand 
swap, we hypothesize that a binding site of HspB1 is in the vicinity 
of this association. In sum, our data suggest a chaperone-target 
mechanism reliant on the recognition of native-like states but stabi-
lization of unfolding intermediates, in a manner that is regulated by 
posttranslational modification.
DISCUSSION
We have investigated how phosphorylation of HspB1 modulates its 
interaction with FLNC. Biophysical and structural studies reveal con-
formational heterogeneity in the 2 strand and the immediately up-
stream PPR, which encompasses the primary HspB1 phosphosite. 
These residues are largely disordered in our construct in solution, 
but are able to make transient intramolecular contacts with 3 and 
a pocket on the edge of the ACD in a manner that is regulated by 
phosphorylation. We observed an interdimer interaction between 
the 2 strand and the 4-8 groove, also the location of a C-terminal 
interdimer interaction (29), in our crystal structure. This is consistent 
with alternative modes of occupancy for the 4-8 groove observed 
in other vertebrate sHsps (5, 35) and hints at intramolecular com-
petition for the binding site in the context of the HspB1 oligomers, 
a mechanism recently proposed for another client interaction (36). 
The conformational plasticity may be the primary source of the modu-
lation in chaperone activity associated with HspB1 phosphorylation, 
exposing binding sites both directly through intramolecular rearrange-
ments and indirectly by causing oligomeric dissociation (22, 23).
Similar heterogeneity of N-terminal residues has been observed 
in other sHsps and shown to regulate assembly, including in HspB5 
and HspB6, both of which can co-assemble with HspB1 in vivo (37). 
The HspB5 2 strand and residues immediately preceding it exist in 
multiple conformations, including bound to 3 both intra- (38) and 
intermonomer (39). Recent crystal structures of HspB6 show no 
resolved density for 2 and support disorder-to-order transitions 
upon interactions made by the N terminus (40). In both HspB5 and 
HspB6, these contacts are controlled by phosphorylation (5, 40). 
Together, these observations indicate a mechanism of tunable function 
via phosphorylation-based modulation of local flexibility that alters 
structure at various levels of organization both within and between 
sHsp family assemblies.
In MLP KO mice, which display heart failure, we detected an 
interaction between HspB1 and FLNC and prevalent phosphoryla-
tion of HspB1 at Ser82. In the MLP KO model, as well as TAC- and 
IsoPE-treated WT mouse hearts, both FLNC and HspB1 were 
up-regulated and partially colocalized. These data evidence an inter-
action enhanced by biomechanical stress. They are consistent with 
previous reports of HspB1 up-regulation in DCM hearts (41, 42), its 
phosphorylation in response to cell or tissue stretch (24, 26), and its 
translocation to sarcomeric Z-discs following muscle exercise or 
mechanical loading (8, 15, 25). Within the proteins, we localized the 
binding in vitro to HspB180–88 and FLNCd18–21. Residues 80 to 88 
encompass parts of the HspB1 PPR and 2 strand, and we see binding 
of this region as a peptide to FLNCd18–21 in a multivalent fashion. 
While phosphorylation of HspB1 increased the association by promot-
ing unbinding and flexibility of the PPR, it did not require the target 
to be unfolded to be recognized. This behavior may be facilitated by 
HspB1 and FLNCd18–21 both containing Ig folds such that chaperone- 
target interfaces mimic intramolecular interactions in HspB1.
Such interaction between an sHsp and a target in its native (rather 
than a misfolded) state is one of only a few observed directly 
(36, 40, 43). These tend to present low-affinity binding modes, in 
keeping with our KD measurements of 130 and 110 M for HspB180–88 
and PHspB180–88, respectively, to FLNCd18–21. Our NMR data support 
that, within HspB1, this segment has a high propensity for disorder. 
Weak interactions involving intrinsically disordered regions are 
overrepresented among temporally fluctuating processes (44), and 
within cardiomyocyte adhesion complexes, functional associations 
have been measured with KDs as weak as 290 M and even 3 mM 
(45, 46). A transient interaction could minimize the obstruction of 
folded FLNC domains from binding partners for normal function, 
e.g., signaling. Phosphorylation of HspB1 would then play a dual 
role, increasing the interaction rate by modulating availability of the 
HspB1 binding site through its release from oligomers while also en-
abling rapid sensing of unfolding FLNC during biomechanical stress.
Because a static affinity measurement will lack this mechanical 
unfolding component, and to be able to selectively target the low- 
affinity complex, we tested this hypothesis by mimicking strain on 
FLNC via extension in the gas phase (32). This approach steers using 
the coulombic repulsion between like charges, and electric field– 
induced protein motions have been shown to reflect functional tra-
jectories (47). Although the free energies of unfolding transitions 
can be influenced by the lack of solvent in these experiments (48), 
the method provides a means of probing differences along the pathway. 
Our experiments revealed that FLNCd18–21 adopts a compact state, 
meaning that multiple interdomain interactions are likely. This co-
heres with predictions of its similarity to FLNAd18–21, whose semi-
compact L shape forms part of a propeller-like FLNAd16–21 region 
with  strand swapping between domain pairs (17, 49). Upon extend-
ing FLNC domains, we consistently observed conformational 
change connected to a biologically relevant transition. Notably, 
when the HspB1 peptide was bound, initial FLNCd18–21 unfolding 
proceeded without its ejection, and an intermediate was stabilized 
by PHspB180–88 relative to HspB180–88. The results are consistent 
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with a phosphorylation-triggered function of HspB1 in regulating 
the extension of FLNC.
The degree of FLNC extension in vivo depends on various factors, 
including its dimer and actin interface strengths, because breakage 
of these would alter the strain borne by the protein along its length 
(31). While these interface strengths have not been reported for 
FLNC, reversible FLNA domain unfolding and actin unbinding are 
energetically similar, and each is more common than dimer rupture 
at physiological forces and low loading rates (50). It will be interesting 
to investigate whether the PHspB1-FLNC interaction is energetically 
favored at a given loading rate, as documented for other mechano-
sensitive processes (51). This could concur with the increase in expres-
sion of both proteins that we observe in hearts of MLP KO mice, the 
most pronounced up-regulation in our study. Functional importance 
could take the form of myoarchitectural integrity maintenance, because 
these animals display severe defects in myofibrillar organization (27). 
FLNC may require chaperoning to function properly under stress 
and avoid adverse structural disruption. In this role, HspB1 binding 
appears to be preventative rather than a response to damage, lowering 
the risk of FLNC hyperextension and aggregation.
Nevertheless, critical force overburdens this system, triggering 
chaperone-assisted selective autophagy (CASA) to clear and degrade 
filamin (FLNA and FLNC reported) in muscle tissue. CASA involves 
the recognition of compromised filamin by the BAG3-HspB8 chap-
erone complex, releasing it from the Z-disc for autophagic degrada-
tion and subsequent triggering of a signaling cascade to stimulate 
filamin transcription (52). While HspB8 is the preferred binding 
partner of BAG3, additional sHsps may interact with this co-chaperone 
too (53). Future work will examine whether (P)HspB1 attenuates 
mechanical unfolding of FLNC in vivo, and whether lowering levels 
of HspB1or inhibiting its phosphorylation affect FLNC aggregation 
and turnover. Colocalization of HspB1 with FLNC and BAG3 at 
skeletal muscle sarcomeric lesions (15) and in our mouse disease 
models, its ability shown here to bind both compact and extending 
filamin, and its known co-assembly with several sHsp paralogs sup-
port HspB1 as a potential key hub in muscle proteostasis (Fig. 4E).
Our results, in the context of these previous reports, point to a 
two-tier sHsp-mediated proteostasis mechanism for maintaining 
FLNC and the myoarchitecture, active at varying tensions. This is 
modulated by the cellular response to mechanical stress, via HspB1 
phosphorylation, exposure of its FLNC binding site, and stabilization 
of the reputed mechanosensitive region of FLNC. Recent reports 
have detailed binding of chaperones to model proteins destabilized 
by the application of force (54, 55). These findings suggest a physio-
logical context for such a mechanism and may provide a new avenue 
for understanding filaminopathies and FLNC-linked cardiac- 
specific diseases.
MATERIALS AND METHODS
Animal experiments
Experimental procedures were performed in accordance with the 
UK Home Office guidelines (project licenses 30/2444 and 30/2977) 
and approved by respective institutional review board. Animals 
were housed in specific pathogen–free conditions, with the only re-
ported positives on health screening over the entire time course of 
these studies being for Tritrichomonas sp. and Entamoeba spp. All 
animals were housed in social groups, provided with food and water 
ad libitum, and maintained on a 12-hour light/12-hour dark cycle 
(150 to 200 lux cool white light-emitting diode light, measured at 
the cage floor). MLP KO mice (27) were backcrossed with C57BL/6J 
for more than six generations before generating homozygous MLP 
KO mice and used at 3 months of age. Age-matched WT C57BL/6J 
were obtained from Harlan.
TAC surgery was performed as described (56) on male C57BL/6J 
mice of 2 to 3 months of age. Sham-operated animals (in which the 
aortic arch was dissected, but no suture was tied) served as controls. 
Adrenergic challenge treatment was done as described (28). Briefly, 
male C57BL/6J mice of 2 to 3 months of age were treated with iso-
prenaline hydrochloride and phenylephrine hydrochloride (IsoPE; 
both from Sigma-Aldrich, UK) at 15 mg kg−1 body weight per day 
each for 14 days in 0.9% saline via subcutaneously implanted micro- 
osmotic pumps (model 1002, ALZET). Pumps were implanted 
during a short surgical procedure carried out under general anesthesia. 
Control mice received pumps delivering 0.9% saline vehicle solution 
only and were monitored in the same way as adrenergic-challenged 
mice. Hearts were harvested 2 weeks after the interventions.
Coimmunoprecipitation
T7-tagged purified recombinant HspB1 protein (1 g) was added to 
10 g of EEF-tagged recombinant FLNCd18–21 in immunoprecipita-
tion (IP) buffer [0.05% Triton X-100, 1% bovine serum albumin, 
protease inhibitors (Roche mini complete EDTA-free tablets) in 
phosphate-buffered saline (PBS)] and incubated for 1 hour, shaking 
at room temperature. This was followed by another 30-min incubation, 
shaking at room temperature after the addition of 0.5 g of anti-T7 
(69522, Novagen) or mouse IgG2b isotype (ab18457, Abcam) anti-
body. Next, 25 l of protein G Sepharose resin (PC-G5, Generon) 
was added to each tube and incubated for 1 hour, shaking at room 
temperature. The beads were then washed four times with IP buffer, 
resuspended in 20 l of 5× SDS sample buffer [312.5 mM tris-HCl 
(pH 6.8), 500 mM dithiothreitol (DTT), 10% SDS, 30% glycerol, 
0.05% bromophenol blue], and boiled at 95°C for 5 min. Immunode-
tection was performed using the anti-T7 (69522, Novagen) or anti- 
EEF/anti-tubulin (YL1/2) (ab6160, Abcam) antibodies.
Analysis of mouse hearts
Animals were sacrificed by cervical dislocation, and hearts were 
flushed with ice-cold PBS and snap-frozen in liquid nitrogen. Immu-
nofluorescence from frozen tissue was performed as described (45) 
using FLNC antibody RR90 (10), pan-cadherin antibody (Sigma), 
and myomesin antibody B4 (Developmental Studies Hybridoma Bank). 
Immunoblotting from total protein extracts was performed as described 
(45) using anti-HspB1 (2442, Cell Signaling Technology), anti-PHspB1 
(Ser82) (2401, Cell Signaling Technology), anti-GAPDH (glycer-
aldehyde phosphate dehydrogenase) (ABS16, Merck), and FLNC [R1899; 
MRC PPU (Medical Research Council Protein Phospho rylation 
and Ubiquitinylation Unit) Reagents and Services, University of 
Dundee] antibodies. IP was performed as described (45) using 5 g 
of FLNC (R1899) antibody. Blotting for HspB1 (2442, Cell Signaling 
Technology) was performed using “VeriBlot” (ab131366, Abcam) 
as secondary horseradish peroxidase conjugate.
Expression and purification of HspB1 constructs
A pET28d(+) vector encoding human HspB1 ACD (residues 84 to 
171) was transformed into Escherichia coli BL21(DE3) cells (Agilent) 
and expressed and purified as described previously (29). For crystallog-
raphy, residue K171 was deleted using a site-directed mutagenesis 
 o
n
 August 7, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Collier et al., Sci. Adv. 2019; 5 : eaav8421     22 May 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
9 of 13
kit (Agilent) and HspB184–170 was expressed and purified as described. 
HspB177–171 and variants thereof were cloned into the same vector 
and expressed in the same manner, with both proteins containing a 
residual Gly-Ser overhang between the tobacco etch virus (TEV) 
protease recognition site and the beginning of the HspB1 sequence. 
Phosphomimic mutations S78E and S82D were introduced using 
site-directed mutagenesis, expressed according to the same protocol, 
and purified as follows: Cells were lysed using a cell press with added 
protease inhibitor cocktail (Roche). Lysate was centrifuged at 
20,000g for 20 min, and the supernatant was filtered and loaded 
onto a HisTrap column in buffer [20 mM tris (pH 8), 150 mm NaCl, 
20 mM imidazole, 5 mM -mercaptoethanol (BME)]. Protein was 
eluted with a gradient to 500 mM imidazole, pooled, and dialyzed 
overnight with TEV protease into the loading buffer at room tem-
perature. The sample was then exchanged into the same buffer with 
addition of 8 M urea by cycles of centrifugation and dilution using 
an Amicon concentrator with 3.5-kDa cutoff. The cleaved and unfolded 
protein was passed over a HisTrap column, and flow-through was 
collected and refolded by overnight dialysis at room temperature into 
100 mM NaCl, 20 mM tris (pH 7.5). Protein was then concentrated, 
and DTT was added to a final concentration of 1 mM for storage at 
−20°C until use. For NMR experiments, HspB1 variants were ex-
pressed in M9 minimal medium containing 13C-labeled d-glucose 
as the only carbon source and 15N-labeled ammonium chloride as 
the only nitrogen source and purified as described, with a final size 
exclusion chromatography (SEC) (Superdex 75, GE Healthcare) 
step for exchange into the NMR buffer. Concentrations were deter-
mined by using a bicinchoninic acid assay (Thermo Pierce).
Full-length human HspB1 (WT or 3P, containing mutations 
S15D, S78D, and S82D) encoded in the pETHSUL vector with 
an N-terminal SUMO and 6× His tag was transformed into E. coli 
BL21(DE3) cells. Cells were used to inoculate a 2-ml LB culture and 
grown for 7 hours at 37°C. Next 500 l of this culture was trans-
ferred to 1 liter of ZYP-5052 autoinduction medium. Cells were 
left to grow overnight at 24°C and 180 rpm until reaching an optical 
density (OD) of 4, and then another 24 hours at 18°C and 180 rpm. 
Cells were harvested and lysed using a cell press with added protease 
inhibitor cocktail, spun at 20,000g for 20 min, and loaded onto a 
HisTrap column in 50 mM sodium phosphate, 250 mM NaCl, 
12.5 mM imidazole, and 5 mM BME (pH 7.5). Protein was eluted 
with a gradient to 500 mM imidazole. Eluent was pooled and dia-
lyzed overnight with SUMO hydrolase at 4°C into the loading 
buffer, and the sample was then passed over a HisTrap column and 
flow-through was collected. This was concentrated and further puri-
fied by SEC using a Superdex 200 16/600 column (GE Healthcare). 
Purity was assessed by SDS–polyacrylamide gel electrophoresis 
(PAGE), and protein was concentrated, flash-frozen, and stored in 
PBS with 1 mM DTT at −80°C. Concentration was determined by 
absorption at 280 nm.
Expression and purification of FLNCd18–21 constructs
The region of human FLNC comprising domains 18 to 21 (WT, 
residues 1943 to 2408 from UniProt ID Q14315; ∆I, residues 1943 
to 2408 excluding 2163 to 2243) was encoded in a modified pET23a/
EEF with C-terminal 6× His and EEF tags. The plasmid was trans-
formed into E. coli BL21(DE3) pLysS cells (Agilent). To generate 
the M construct, mutations E2136R and I2138E were introduced 
by site-directed mutagenesis. Cells were grown in LB at 37°C until 
an OD600 of 0.6 to 0.8 was reached. Isopropylthiogalactoside was 
then added to a final concentration of 0.5 mM to induce expression 
for 16 to 18 hours at 21°C. Cells were resuspended in 300 mM NaCl, 
50 mm tris, 20 mM imidazole, and 5 mM BME (pH 7.7) containing 
protease inhibitor cocktail and lysed using a cell press. Lysate was 
clarified by centrifugation at 20,000g for 20 min, filtered through a 
0.22-m filter, and applied to a 5-ml HisTrap column (GE Health-
care). Protein was eluted with a gradient to 500 mM imidazole, 
pooled, concentrated using an Amicon centrifugal concentrator 
with a molecular weight cutoff of 30 kDa, and further purified by 
SEC using a Superdex 200 (10/300) column (GE Healthcare) at 4°C 
equilibrated in MS buffer [200 mM ammonium acetate (pH 6.9)]. 
Purity was assessed by SDS-PAGE, and protein was stored in MS 
buffer at −80°C and used for experiments within 2 weeks of purifi-
cation, after noticing in initial preparations some propensity for 
destabilization and aggregation following long-term storage.
Expression and purification of FLNCd20–21 constructs
Cloning of the FLNCd20–21 constructs was performed as described 
previously (57) using the p3NH expression vector carrying an 
N-terminal 6× His tag. FLNCd20–21 encompassed residues 2132 to 
2406 and ∆FLNCd20–21 encompassed residues 2155 to 2406. For 
protein expression, 6 × 500 ml autoinduction medium (no trace 
metal mix added) supplemented with chloramphenicol (34 g ml−1) 
and kanamycin (50 g ml−1) was inoculated with 20 ml of overnight 
culture and grown at 37°C to OD600 of 0.8 shaking at 150 rpm. 
Then, the temperature was reduced to 20°C, and after 12 hours, the 
culture was centrifuged (4°C, 45,000g) and the resulting cell pellet 
was either processed immediately or frozen in liquid nitrogen and 
stored at −80°C.
Cell pellets were resuspended in 100 ml of lysis buffer [1× PBS, 
20 mM imidazole, 2 M urea, (pH 7.4)] supplemented with 50 l of 
deoxyribonuclease I (10 mg ml−1) and sonicated twice for 3 min 
(50% amplitude; 1 s pulse on; 1 s pulse off, Branson Sonifier W-450 
D). The lysate was clarified by centrifugation, and the supernatant 
was subsequently loaded onto a 5-ml HisTrap FF crude (GE Health-
care) column pre-equilibrated with lysis buffer. Protein was eluted 
with a step gradient using elution buffer [1× PBS, 500 mM imidazole, 
2 M urea (pH 7.4)]. Individual fractions of purified protein were 
frozen in liquid nitrogen without concentrating and stored at −80°C 
until further use. Immediately before experiments, protein was ex-
changed into MS buffer [200 mM ammonium acetate (pH 6.9)] using 
a Superdex 200 (10/300) column (GE Healthcare) at 4°C. Concen-
tration was measured by absorbance at 280 nm, and the protein was 
diluted to a concentration of 5 M for experiments.
Peptides
Peptides were purchased from Biomatik at 99+% purity with acetyl-
ated N termini when the N-terminal residue was Glu. Lyophilized 
peptides were resuspended in ddH2O to a stock concentration of 
15 mM, flash-frozen, and stored at −20°C until use.
Crystallization and structure determination
Crystals were obtained following initial screens using HspB184–170 
(18 mg ml−1) with a fourfold molar excess of one of several peptide 
mimics of the N-terminal region varying in length and degree of 
phosphorylation. Several combinations yielded reproducible crystals 
but most exhibited poor diffraction (>7 Å). Following rounds of opti-
mization using hanging-drop plates (VDX; Hampton Research), 
we collected a dataset from a crystal grown from 5 mM peptide 
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P82HspB176–88 and HspB184–170 (16 mg ml−1) that allowed for structure 
determination (table S1). Drops were set using a protein-peptide 
mixture in PBS (pH 7.0) and equilibrated against 22% polyethylene 
glycol (PEG) 3350, 0.02 M sodium potassium diphosphate, and 
0.1 M bis-tris propane (pH 7.5). The protein was mixed 1:1 with the 
crystallization solution (0.9 l each), and drops were left to equili-
brate at room temperature against a 1-ml reservoir. Crystals grew 
within 2 days and continued growing to maximum size within 6 
days. Crystals were cryoprotected by serial transfer from the drop to 
the crystallization solution containing additional 10% PEG 400 and 
5% followed by 10% glycerol, before being flash-frozen in liquid N2. 
Diffraction data were collected under cryogenic conditions on 
beamline I04-1 at Diamond Light Source (Harwell, UK).
Diffraction data were integrated using iMosflm and scaled and 
merged using Aimless in the CCP4 suite with truncation at 2.1 Å. 
Phases were determined by molecular replacement using Phaser with 
a previous HspB1 x-ray structure input as a search model (PDB 
4MJH, modified by removal of flexible loops, bound C-terminal 
peptide, and 2 strands). The four dimers in the asymmetric unit 
were completed through cycles of manual building in Coot and re-
finement in Phenix imposing noncrystallographic symmetry (NCS) 
restraints. Peptide density was then apparent in the 2Fo-Fc and Fo-Fc 
maps next to one monomer within each of the four dimers. Peptide 
fragments were placed through cycles of manual building in Coot 
and refinement in PHENIX, now without NCS restraints and with 
treatment of TLS (translation-libration-screw) parameters. Most peptide 
side chains remained poorly resolved throughout cycles of refinement 
in contrast to the well-resolved core. In addition, the peptide density 
never extended beyond a length accommodating 3 to 6 of 11 residues.
Thus, we attempted to deduce the orientation and identity of the 
residues captured in the density. In light of data suggesting an intra-
molecular interaction, we treated each peptide as though extending 
toward the 2 strand of the monomer to which it is bound. The ques-
tion of which residues occupy the binding pocket was thus restricted 
to those that could reach from the 2 strand if the chain was contin-
uous, eliminating the latter half of the peptide and leaving, roughly, 
ALSRQL. The lack of density for the remaining half of the peptide is 
unsurprising, because most of these residues are repeated in the ACD 
and would compete for contacts with their counterparts that are cova-
lently bound to the core and exist at a much higher local concentra-
tion, leaving this portion of the peptide no site to bind and thus too 
disordered to give rise to observable electron density. In each peptide 
region, the clearest side-chain electron density pointed into a pocket 
between Phe104 and Gly161 that could not accommodate a bulky resi-
due but must be larger than alanine. Backbone density extends two 
residues N-terminally from this pocket, excluding Leu77 and implicat-
ing Ser78 or Leu81. Modeling each of these and refining caused negligible 
difference in Rwork and Rfree; therefore, based on close examination of 
the resulting Fo-Fc maps and potential chemical contacts within the 
pocket, as well as the NMR data supporting dynamic changes in this 
region of the ACD upon Ser78 mutation, we placed Ser78 into this loca-
tion. At each dimer interface, Cys137 density evidenced both disulfide- 
bonded and reduced conformations, and so we modeled each of these 
with occupancy 0.5 in all cases, consistent with the labile nature of this 
bond (29). The final model had Rwork/Rfree of 21%/25%.
NMR spectroscopy
All NMR spectroscopy experiments were recorded at 298 K on a 
14.1-T Varian INOVA spectrometer equipped with a 5-mm z-axis 
gradient triple resonance room temperature probe. Spectra were 
processed with NMRPipe and analyzed with NMRFAM-Sparky. 
Two-dimensional sensitivity-enhanced 1H-15N heteronuclear single- 
quantum coherence (HSQC) spectra were acquired with 1H (15N) 
512 (64) complex points, spectral widths of 8012 Hz (1800 Hz), 
maximum acquisition times of 64 ms (35.6 ms), an interscan delay 
of 1 s, and four scans per free induction decay for a total acquisition 
time of 19 min. 13C,15N-2PHspB177–171 was prepared at a final con-
centration of 0.9 mM in 30 mM sodium phosphate, 2 mM EDTA 
(pH 7.0) for resonance assignments, wherein HNCA, HNCO, and 
HN(CA)CO spectra were recorded. The assigned 1HN, 15N, 13CO, 
and 13C chemical shifts were analyzed with TALOS-N and RCI to 
respectively estimate the secondary structure and N-H order parameters.
Protonated, 15N-labeled proteins were prepared at 0.9 mM 
(2PHspB177–171) or 1 mM (HspB184–171) for 15N relaxation studies. 
Standard pulse sequences to measure transverse relaxation times 
(T2), 15N heteronuclear nuclear Overhauser enhancements (hetNOE), 
and 15N CPMG (Carr-Purcell-Meiboom-Gill sequence) relaxation 
dispersion were used. The T2 experiments contained eight delay 
times up to 154 ms and an interscan delay of 2 s. The intensity 
changes over time (I/I0) were fit to an exponential decay, and values 
are reported as rates (i.e., 1/T2) for convenience. hetNOE experiments 
contained an interscan delay of 8 s, with values representing the 
intensity upon amide proton saturation divided by the intensity in 
its absence. CPMG relaxation dispersion experiments were recorded 
with variable delays between 180° pulses in the CPMG pulse train 
(CPMG = 4CPMG−1). A constant relaxation delay of 39 ms for the 
CPMG period and 20 CPMG values ranging from 54 to 950 Hz were 
used. Peak shapes were fit with FuDA to extract peak intensities, 
which were then converted into R2,eff values using the following 
relation: R2,eff(CPMG) = −1/Trelax ln[I(CPMG)/I(0)], where I(CPMG) 
is the intensity of a peak at CPMG, Trelax is the constant relaxation 
delay of 39 ms that was absent in the reference spectrum, and I(0) is 
the intensity of a peak in the reference spectrum. Two duplicate CPMG 
points were recorded in each dispersion dataset for error analysis, 
and uncertainties in R2,eff were calculated using the SD of peak in-
tensities from such duplicate measurements. From plots of R2,eff as 
a function of CPMG, Rex was determined by taking the difference of 
R2,eff (54 Hz) and R2,eff (950 Hz) with error bars representing the 
propagated errors in R2,eff.
Native IM-MS
Because HspB1 can form disulfide-linked dimers, experiments in-
volving the ACD were performed in the presence of 10-fold molar 
excess DTT. Gold-plated capillaries were prepared in-house. Native 
MS and IM-MS data were recorded on a Synapt G1 mass spectrometer 
(Waters) modified for the transmission of intact noncovalent pro-
tein complexes. HspB177–171 variants were analyzed at a concentration 
of 10 M in 200 mM ammonium acetate (pH 6.9). Spectra of 
FLNCd18–21 and peptide titrations were recorded with the following 
settings: capillary, 1.50 kV; sample cone, 30 V; extractor cone, 3 V; 
backing pressure, 3.8 mbar; trap gas (argon), 4 ml min−1; trap and 
transfer cell voltages, 5 V. FLNC concentration was held constant at 
5 M, and peptide concentration (HspB180–88 or PHspB180–88) varied 
from 5 to 160 M. Peptides and protein were mixed in 200 mM 
ammonium acetate (pH 6.9) immediately before data collection. 
Nanoelectrospray ionization was performed in the presence of ace-
tonitrile vapor to promote charge reduction and maintenance of 
noncovalent contacts and native structure. A minimum of three 
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technical repeats were collected at each ratio. KDs were obtained by 
fitting the titration data using a standard binding model of three 
equivalent binding sites implemented in UniDec software (58). 
Contour plots were generated using a custom script to minimally 
smooth the data, sort it into 5 m/z bins, and normalize intensity 
across the input spectra. To control for nonspecific adduct forma-
tion during desolvation, spectra were collected using an excess of 
HspB180–88 peptide with scrambled sequence. To control for the 
possibility of promiscuity in recognition of Ig domain folds by 
HspB1 flexible termini, spectra were collected using an excess of 
peptide mimicking HspB1 C-terminal residues 177 to 186.
Gas-phase unfolding experiments were performed using the 
same conditions as described for peptide titrations, with an ion mo-
bility cell gas pressure of 0.53 mbar (N2) and a flow rate of 22 ml 
min−1, at a wave velocity of 300 m s−1 and a wave height of 7.0 
V. Collision voltage into the trap cell varied from 5 to 180 V or until 
signal was no longer present, in 5-V increments below 100 V, and in 
10-V increments above 100 V. All data shown here for complexes 
were performed with 16-fold molar excess of peptide, excepting 
controls in fig. S4 as described in the figure legend. Plots were visu-
alized in PULSAR (59) and are representative of experiments per-
formed with three different protein batch preparations and three 
peptide-to-protein ratios. To extract activation thresholds for tran-
sitions as indicated in Fig. 4 and figs. S6 and S7, the Unfolding Ex-
traction/Analysis tool in PULSAR was used. To quantify peptide 
dissociation with activation, the 13+ singly bound peak was selected 
in the quadrupole with low-mass and high-mass resolutions of 7.2 
and 6.9, respectively, and trap voltage ramped as described for the 
unfolding experiments. Data were smoothed minimally in MassLynx, 
and peak intensities were extracted, summed as bound or unbound, 
and converted to percentages. A subtraction was applied to correct 
for nonspecific adduction at potentials below 30 V based on activa-
tion trials with nonspecific controls.
Calculation of CCSs
CCSs () of models from the PDB (trimmed in PyMOL as described 
in the Supplementary Materials) were calculated by the projection 
approximation method using IMPACT (60), accounting for N2 as 
the collision gas. To calculate CCSs of FLNCd18–21, native mass 
spectra of -lactoglobulin and avidin (Sigma) were collected under 
identical drift cell conditions (as described for titration experi-
ments, with the mobility wave height lowered to 5.5 V) and used to 
construct a calibration in PULSAR, which had R2 > 0.96, using a 
power law linear fit.
Visualization of protein structures
All renderings were generated in PyMOL using structures as de-
scribed in figure legends. To construct the FLNCd20–21 model in fig. 
S6A, FLNAd20–21 was isolated from PDB file 2J3S and used as a tem-
plate for the sculptor tool in PHENIX, with the FLNC sequence 
threaded onto the FLNA structure.
SDS-PAGE aggregation assay
HspB1 (WT or 3P) was mixed with FLNCd18–21 at a 2:1 ratio (80 and 
40 M, respectively) in 200 mM ammonium acetate (pH 6.9) with 
500 M DTT and incubated at 25°C for 90 min. Aliquots were 
removed periodically and pelleted at 13,000g at 10°C for 10 min. 
Soluble fractions were diluted threefold with 200 mM ammonium 
acetate for analysis by SDS-PAGE, and pellets were resuspended in 
the same volume of 200 mM ammonium acetate and solubilized 
upon addition of the SDS-PAGE loading buffer. Gel bands were 
quantified by densitometry, using the raw intensities of FLNC and 
HspB1 bands to extract relative soluble and insoluble proportions at 
each time point.
MD simulations
Two simulations of the HspB1 dimer were prepared using a previous 
ACD crystal structure (PDB: 4MJH). The system was immersed 
into a TIP3P water box and neutralized with 0.15 M Na+ and Cl− ions. 
Simulations used the AMBER99SB force field and NAMD2.9 MD 
engine, with the SHAKE algorithm constraining heavy atoms distances 
and particle mesh Ewald for treating the electrostatic interactions in 
periodic boundary conditions. The systems were first minimized with 
2000 conjugate gradient steps and subsequently simulated using a 
2-fs time step. Systems were equilibrated in the nPT ensemble for 
0.5 ns, with a 10 kcal mol−1 constrain on protein alpha carbons. 
Values of 300 K and 1 atm were imposed by Langevin dynamics, 
using a damping constant of 1 ps−1, a piston period of 200 fs, and a 
piston decay of 50 fs. Constraints were subsequently removed, and 
systems were simulated in the nVT ensemble at 300 K for 1 ns. Last, 
production runs were conducted in the nPT ensemble (300 K and 
1 atm) for 1 s. We extracted the coordinates of each individual mono-
mer every 0.1 ns, yielding 1000 frames per monomer. We calculated 
the order parameter (S2 of N-H bond vectors) of the datasets inde-
pendently with a Python code developed in house.
Statistical analysis
All data are presented as the mean of at least three independent 
experiments, with error bars as defined in figure legends for Figs. 2 
and 4 and fig. S3.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/5/eaav8421/DC1
Fig. S1. FLNC and HspB1 are up-regulated and partially colocalize in mechanically challenged 
mouse heart.
Fig. S2. Phosphorylation of HspB1 modulates the interaction with FLNCd18–21.
Fig. S3. Solution NMR of truncated HspB1 variants reveals changes in the dynamics of HspB1 
ACD residues upon phosphomimicry.
Fig. S4. A crystal structure of the HspB1 ACD in complex with a peptide mimic of N-terminal 
residues reveals conformational heterogeneity of the PPR and 2 strand.
Fig. S5. (P)HspB180–88 binds FLNCd18–21 specifically with phosphorylation modifying the 
extension of the complex.
Fig. S6. Coulombically steered unfolding can prompt biologically relevant transitions within 
FLNC.
Fig. S7. Stabilization of an intermediate FLNC unfolding state by HspB1 phosphopeptide is 
observed across charge states and instrument conditions.
Table S1. Data collection and refinement statistics for HspB184–170 in complex with PPR 
peptide.
Table S2. Guide to nomenclature for recombinant proteins and synthetic peptides used in this 
study.
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